TG THERAPEUTICS, INC. Income Tax Expense
TG THERAPEUTICS, INC. (TGTX) reported Income Tax Expense of $2.45 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-05
- TG THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2026-06-30 was $2.45M, a 10.25% decline year-over-year.
- TG THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2026-03-31 was $586.00K, a 43.63% increase year-over-year.
- TG THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2025-12-31 was $22.06M, a 939.40% increase year-over-year.
- TG THERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2025-09-30 was -$364.99M, a 94168.56% decline year-over-year.
- TG THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2025 was -$339.79M, a 15468.11% decline from fiscal 2024.
- TG THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2024 was $2.21M, a 466.92% increase from fiscal 2023.
- TG THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2023 was $390.00K.
- TG THERAPEUTICS, INC. income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed | Income Tax Expense (Benefit) 13 month | Income Tax Expense (Benefit) 16 month | Income Tax Expense (Benefit) 19 month | Income Tax Expense (Benefit) 22 month | Income Tax Expense (Benefit) 25 month | Income Tax Expense (Benefit) 28 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.45M 10-Q · filed 2026-08-05 | $3.04M 10-Q · filed 2026-08-05 | $25.09M derived: sum of 3 quarters · filed 2026-08-05 | -$339.89M derived: sum of 4 quarters · filed 2026-08-05 | |||||||
| 2026-03-31 | $586.00K 10-Q · filed 2026-05-06 | $22.64M derived: sum of 2 quarters · filed 2026-05-06 | -$342.34M derived: sum of 3 quarters · filed 2026-05-06 | -$339.61M derived: sum of 4 quarters · filed 2026-08-05 | |||||||
| 2025-12-31 | $22.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$342.93M derived: sum of 2 quarters · filed 2026-02-27 | -$340.20M derived: sum of 3 quarters · filed 2026-08-05 | -$339.79M 10-K · filed 2026-02-27 | |||||||
| 2025-09-30 | -$364.99M 10-Q · filed 2025-11-05 | -$362.25M derived: sum of 2 quarters · filed 2026-08-05 | -$361.85M 10-Q · filed 2025-11-05 | -$359.72M derived: sum of 4 quarters · filed 2026-08-05 | |||||||
| 2025-06-30 | $2.73M 10-Q · filed 2026-08-05 | $3.14M 10-Q · filed 2026-08-05 | $5.26M derived: sum of 3 quarters · filed 2026-08-05 | $5.65M derived: sum of 4 quarters · filed 2026-08-05 | |||||||
| 2025-03-31 | $408.00K 10-Q · filed 2026-05-06 | $2.53M derived: sum of 2 quarters · filed 2026-05-06 | $2.92M derived: sum of 3 quarters · filed 2026-05-06 | $2.59M derived: sum of 4 quarters · filed 2026-05-06 | |||||||
| 2024-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.51M derived: sum of 2 quarters · filed 2026-02-27 | $2.18M derived: sum of 3 quarters · filed 2026-02-27 | $2.21M 10-K · filed 2026-02-27 | |||||||
| 2024-09-30 | $388.00K 10-Q · filed 2025-11-05 | $60.00K derived: sum of 2 quarters · filed 2025-11-05 | $89.00K 10-Q · filed 2025-11-05 | $479.00K derived: sum of 4 quarters · filed 2026-02-27 | |||||||
| 2024-06-30 | -$328.00K 10-Q · filed 2025-08-08 | -$299.00K 10-Q · filed 2025-08-08 | $91.00K derived: sum of 3 quarters · filed 2026-02-27 | $91.00K derived: sum of 4 quarters · filed 2026-02-27 | |||||||
| 2024-03-31 | $29.00K 10-Q · filed 2025-05-09 | $419.00K derived: sum of 2 quarters · filed 2026-02-27 | $419.00K derived: sum of 3 quarters · filed 2026-02-27 | $419.00K derived: sum of 4 quarters · filed 2026-02-27 | |||||||
| 2023-12-31 | $390.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $390.00K derived: sum of 2 quarters · filed 2026-02-27 | $390.00K derived: sum of 3 quarters · filed 2026-02-27 | $390.00K 10-K · filed 2026-02-27 | |||||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||||||||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | |||||||||
| 2022-12-31 | $0.00 10-K · filed 2025-03-03 | ||||||||||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 | ||||||||||
| 2020-12-31 | $0.00 10-K · filed 2023-03-01 | ||||||||||
| 2019-12-31 | $0.00 10-K · filed 2022-03-01 | ||||||||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 | ||||||||||
| 2017-12-31 | $0.00 10-K · filed 2020-03-02 | ||||||||||
| 2016-12-31 | $0.00 10-K · filed 2019-03-01 | ||||||||||
| 2015-12-31 | $0.00 10-K · filed 2018-03-15 | ||||||||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-16 | ||||||||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $0.00 derived: sum of 4 quarters · filed 2016-03-15 | $330.00K 10-Q · filed 2014-05-14 | ||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $0.00 derived: sum of 2 quarters · filed 2016-03-15 | $0.00 derived: sum of 3 quarters · filed 2016-03-15 | $0.00 10-K · filed 2016-03-15 | $330.00K 10-K · filed 2014-03-07 | ||||||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $300.00K derived: sum of 4 quarters · filed 2016-11-09 | $330.00K 10-Q · filed 2013-11-14 | ||||||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | $300.00K derived: sum of 3 quarters · filed 2016-11-09 | $330.00K 10-Q · filed 2013-08-09 | |||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $300.00K derived: sum of 2 quarters · filed 2016-11-09 | $330.00K 10-Q · filed 2013-05-14 | ||||||||
| 2012-12-31 | $300.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2016-11-09 | $300.00K 10-Q · filed 2016-11-09 | $330.00K 10-K · filed 2013-03-21 | $330.00K 10-K · filed 2013-03-21 | |||||||
| 2012-12-30 | $330.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2014-07-24 | $330.00K derived: sum of 2 quarters · filed 2014-07-24 | $330.00K derived: sum of 3 quarters · filed 2014-07-24 | $330.00K 10-Q · filed 2014-07-24 | |||||||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | ||||||||
| 2012-06-30 | $0.00 10-Q · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | |||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-14 | ||||||||||
| 2011-12-31 | $0.00 10-K · filed 2013-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |